Gain Therapeutics, Inc. (GANX)

NASDAQ: GANX · IEX Real-Time Price · USD

2.630

-0.060 (-2.23%)

At close: May 17, 2024, 4:00 PM

2.720

+0.090 (3.42%)

After-hours: May 17, 2024, 6:30 PM EDT

Gain Therapeutics Market Cap

Gain Therapeutics has a market cap or net worth of $46.89 million as of May 17, 2024. Its market cap has decreased by -23.88% in one year.

Market Cap

46.89M

Enterprise Value

35.12M

1-Year Change

-23.88%

Ranking

#4624

Market Cap Chart

Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $46.89M, a decrease of -62.38%. That is a compound annual growth rate of -26.58%.

Market Cap History

Date	Market Cap	% Change
May 16, 2024	48.60M	2.75%
May 15, 2024	47.30M	12.09%
May 14, 2024	42.20M	7.38%
May 13, 2024	39.30M	-3.44%
May 10, 2024	40.70M	-1.21%
May 9, 2024	41.20M	-5.29%
May 8, 2024	43.50M	-7.45%
May 7, 2024	47.00M	1.73%
May 6, 2024	46.20M	-3.75%
May 3, 2024	48.00M	1.05%
May 2, 2024	47.50M	-1.45%
May 1, 2024	48.20M	1.47%
Apr 30, 2024	47.50M	-2.46%
Apr 29, 2024	48.70M	-0.81%
Apr 26, 2024	49.10M	-1.41%
Apr 25, 2024	49.80M	-3.68%
Apr 24, 2024	51.70M	-6.00%
Apr 23, 2024	55.00M	7.00%
Apr 22, 2024	51.40M	-0.39%
Apr 19, 2024	51.60M	0.98%
Apr 18, 2024	51.10M	-0.97%
Apr 17, 2024	51.60M	0.58%
Apr 16, 2024	51.30M	2.40%
Apr 15, 2024	50.10M	-1.96%
Apr 12, 2024	51.10M	-6.24%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
NeueHealth	50.33M
Dyadic International	50.29M
Clene	50.08M
Aligos Therapeutics	49.52M
Reviva Pharmaceuticals Holdings	48.02M
Cutera	47.47M
LENSAR	47.30M
Carmell Therapeutics	47.27M

Market Cap Rankings